Category: PrimeCuts

Commentary by Josh Olstein MD, Associate Editor, Clinical Correlations

As a future gastroenterologist, I was drawn to a study in the October 4^th edition of the New England Journal of Medicine that compared CT …

Commentary by Danise Schiliro-Chuang MD, NYU Chief Resident

Let’s start on the theme of cardiovascular disease risk reduction, a topic making headlines this week. A September 28 New York Times article previews the release of …

Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations

The sensation of déjà vu was likely very common this week. First, we experienced a flashback to 1994 when we saw OJ in handcuffs again…and …

Commentary by Henry Tran, MD

There continues to be accumulating evidence of the beneficial effects of statin therapy.  Coming on the heels of the SPARCL trial, which demonstrated that high-dose atorvastatin reduces the incidence …

Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program

Anemia is very common in ICU patients, but whether to treat this anemia and prevent the need for transfusions is currently …

Commentary by Michael Poles MD, Associate Editor Clinical Correlations

The latest estimates from the US Census Bureau suggest that the number of uninsured Americans has increased from 44.8 million in 2005 to roughly 47 million in 2006. This jump of …

Commentary by Josh Olstein MD, Associate Editor, Clinical Correlations

This week, the most popular health-care related story in the lay press was the news about Medicare’s plan to no longer cover the additional costs …

Commentary By: Neil Shapiro, M.D. Editor-in-Chief Clinical Correlations

As summer winds down and the weather prematurely cools off, this weeks shortcuts finds us focusing on the genetics of coumadin treatment, the very controversial hpv …